Campbell Capital Management Inc Pfizer Inc Transaction History

Campbell Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 11, 2022	SELL	$45.75 - $56.69 $5.8 Million - $7.19 Million	-126,857 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$41.32 - $61.25 $206,600 - $306,250	5,000 Added 4.1%	126,857 $7.49 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $60,837 - $78,151	-1,550 Reduced 1.26%	121,857 $5.24 Million
Q2 2021 Jul 09, 2021	SELL	$35.91 - $40.68 $17,955 - $20,340	-500 Reduced 0.4%	123,407 $4.83 Million
Q1 2021 Apr 06, 2021	SELL	$33.49 - $37.77 $112,961 - $127,398	-3,373 Reduced 2.65%	123,907 $4.49 Million
Q4 2020 Jan 13, 2021	SELL	$33.47 - $42.56 $98,736 - $125,552	-2,950 Reduced 2.27%	127,280 $4.73 Million
Q3 2020 Oct 01, 2020	BUY	$31.75 - $37.25 $4.13 Million - $4.85 Million	130,230 New	130,230 $4.78 Million

3,258

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Campbell Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Campbell Capital Management Inc with notifications on news.